Pro Medicus Statistics
Total Valuation
Pro Medicus has a market cap or net worth of 16.41 billion. The enterprise value is 16.32 billion.
| Market Cap | 16.41B |
| Enterprise Value | 16.32B |
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | Sep 4, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 53.00M |
Valuation Ratios
The trailing PE ratio is 297.07.
| PE Ratio | 297.07 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 146.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 231.94, with an EV/FCF ratio of 299.41.
| EV / Earnings | 295.35 |
| EV / Sales | 163.20 |
| EV / EBITDA | 231.94 |
| EV / EBIT | 233.69 |
| EV / FCF | 299.41 |
Financial Position
The company has a current ratio of 5.98, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.98 |
| Quick Ratio | 5.89 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.03 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 50.72% and return on invested capital (ROIC) is 42.67%.
| Return on Equity (ROE) | 50.72% |
| Return on Assets (ROA) | 30.68% |
| Return on Capital (ROIC) | 42.67% |
| Revenue Per Employee | 1.56M |
| Profits Per Employee | 800,582 |
| Employee Count | 69 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 5.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +138.43% in the last 52 weeks. The beta is 0.54, so Pro Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +138.43% |
| 50-Day Moving Average | 148.06 |
| 200-Day Moving Average | 106.16 |
| Relative Strength Index (RSI) | 54.73 |
| Average Volume (20 Days) | 156 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pro Medicus had revenue of 107.75 million and earned 55.24 million in profits. Earnings per share was 0.53.
| Revenue | 107.75M |
| Gross Profit | 107.55M |
| Operating Income | 75.25M |
| Pretax Income | 77.73M |
| Net Income | 55.24M |
| EBITDA | 75.43M |
| EBIT | 75.25M |
| Earnings Per Share (EPS) | 0.53 |
Balance Sheet
The company has 103.70 million in cash and 1.38 million in debt, giving a net cash position of 102.32 million.
| Cash & Cash Equivalents | 103.70M |
| Total Debt | 1.38M |
| Net Cash | 102.32M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 125.25M |
| Book Value Per Share | 1.20 |
| Working Capital | 114.76M |
Cash Flow
In the last 12 months, operating cash flow was 54.70 million and capital expenditures -205,498, giving a free cash flow of 54.49 million.
| Operating Cash Flow | 54.70M |
| Capital Expenditures | -205,498 |
| Free Cash Flow | 54.49M |
| FCF Per Share | n/a |
Margins
Gross margin is 99.81%, with operating and profit margins of 69.84% and 51.27%.
| Gross Margin | 99.81% |
| Operating Margin | 69.84% |
| Pretax Margin | 72.13% |
| Profit Margin | 51.27% |
| EBITDA Margin | 70.00% |
| EBIT Margin | 69.84% |
| FCF Margin | 50.57% |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.10%.
| Dividend Per Share | 0.15 |
| Dividend Yield | 0.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 44.15% |
| Buyback Yield | -0.06% |
| Shareholder Yield | 0.03% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pro Medicus has an Altman Z-Score of 87.37.
| Altman Z-Score | 87.37 |
| Piotroski F-Score | n/a |